Webinar Sponsored &
Please join us as Dr. Nico van Zyl shares his
insights on the changes in genetic testing and recent developments
in the field of genetics and genomics. His presentation will
also consider the impact of new genetic and genomic technologies
on the Global and Canadian Life Insurance markets and will
discuss Bill S-201.
Please note that the sound for this webcast
will be delivered through your computer.
Dr. Nico van Zyl
AVP, Medical Director
Dr. Nico van Zyl obtained his medical degree at the University
of Witwatersrand, Johannesburg, South Africa in 1995 and completed
his internship in 1996 at Tygerberg Hospital, Cape Town. He
moved to the United Kingdom in 1997, where he built a successful
medical practice specializing in adult psychiatry.
In 2011, Dr. van Zyl joined Hannover Re Africa based in Johannesburg
and was appointed to the position of Chief Medical Officer.
In this role, he was actively involved in the South African
Life Insurance Industry and held the position of Deputy Convenor
of the Medical and Underwriting Standing Committee of the
He moved to Denver, Colorado in 2017 to take up the role
of Assistant Vice President and Medical Director for Hannover
Life Re America. Dr van Zyl also holds a Master of Health
Informatics degree from the University College London (UCL)
which he was awarded in 2010. He has a keen interest in the
use of technology and its application to clinical and insurance
medicine including underwriting.